Tan Xiaodong, Egami Hiroshi, Ishikawa Shinji, Sugita Hideki, Kamohara Hidenobu, Nakagawa Masahide, Nozawa Fumiaki, Abe Michio, Ogawa Michio
Department of Surgery II, Kumamoto University Medical School, Kumamoto, Japan.
Int J Oncol. 2005 May;26(5):1283-9.
Epidermal growth factor receptor (EGFR) mediated mitogen-activated protein kinase kinase (MEK)/extracellular signal-regulated kinase (ERK) signaling pathway was isolated as invasion-metastasis related factor in pancreatic cancer in our previous studies. Matrix metalloproteinase-7 (MMP-7) and tight junction (TJ) proteins are indicated to be involved in cancer invasion-metastasis. To clarify the underlying mechanism of involvement of MMP-7 in cancer invasion, western blotting, invasion assay and immunohistochemistry were performed in dissociated (PC-1.0 and AsPC-1) and non-dissociated (PC-1 and Capan-2) pancreatic cancer cells, as well as pancreatic cancer tissues. Intracellular MMP-7 protein presented as pre-proenzyme and its expression was decreased by AG1478 (EGFR inhibitor) or U0126 (MEK inhibitor) treatment in pancreatic cancer cells. Activated MMP-7 protein was only detected in the medium of PC-1.0 and AsPC-1 cells, but not detected in the medium of PC-1 and Capan-2 cells. Moreover, MMP-7 treatment significant induced the dissociation of cell colonies in PC-1 and Capan-2 cells. Synchronously, TJ structure was apparently disrupted and translocation of TJ proteins to cytoplasm or extracellular medium was induced in PC-1 and Capan-2 cells. Furthermore, MMP-7 treatment markedly increased the in vitro invasion of PC-1 and Capan-2 cells. In addition, MMP-7 expression at the invasive front was obviously stronger than that at the center of pancreatic cancer tissues. Activation of MMP-7 protein is closely involved in disruption of TJ structure and consequent induction of cell dissociation as well as invasion in pancreatic cancer. EGFR mediated MEK/ERK signaling pathway is implied to be involved in regulation of MMP-7 expression in pancreatic cancer cells.
在我们之前的研究中,表皮生长因子受体(EGFR)介导的丝裂原活化蛋白激酶激酶(MEK)/细胞外信号调节激酶(ERK)信号通路被确认为胰腺癌中与侵袭转移相关的因子。基质金属蛋白酶-7(MMP-7)和紧密连接(TJ)蛋白被认为参与癌症侵袭转移过程。为阐明MMP-7参与癌症侵袭的潜在机制,我们对解离的(PC-1.0和AsPC-1)和未解离的(PC-1和Capan-2)胰腺癌细胞以及胰腺癌组织进行了蛋白质印迹法、侵袭试验和免疫组织化学检测。在胰腺癌细胞中,细胞内MMP-7蛋白以酶原形式存在,其表达在接受AG1478(EGFR抑制剂)或U0126(MEK抑制剂)处理后降低。仅在PC-1.0和AsPC-1细胞的培养基中检测到活化的MMP-7蛋白,而在PC-1和Capan-2细胞的培养基中未检测到。此外,MMP-7处理显著诱导PC-1和Capan-2细胞的细胞集落解离。同时,PC-1和Capan-2细胞中的TJ结构明显破坏,TJ蛋白向细胞质或细胞外培养基转移。此外,MMP-7处理显著增加了PC-1和Capan-2细胞的体外侵袭能力。另外,在胰腺癌组织的侵袭前沿,MMP-7的表达明显强于肿瘤中心。MMP-7蛋白的激活与胰腺癌中TJ结构的破坏、细胞解离的诱导以及侵袭密切相关。EGFR介导的MEK/ERK信号通路可能参与调节胰腺癌细胞中MMP-7的表达。